Abstract
Carcinoid tumors are associated with the production of a number of bioactive substances that might deposit on the endocardium (endocardial fibroelastosis) and produce cardiac failure. Carcinoid heart disease usually presents as right-sided valvular heart disease. Even if the diagnosis is frequently made by transthoracic echocardiography, cardiac magnetic resonance imaging adds valuable information when evaluating cardiac structures that might be difficult to analyze on echocardiography.
MeSH terms
-
Adult
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Carcinoid Heart Disease / diagnosis*
-
Carcinoid Heart Disease / drug therapy
-
Carcinoid Heart Disease / surgery
-
Carcinoid Tumor / drug therapy
-
Carcinoid Tumor / secondary*
-
Carcinoid Tumor / surgery
-
Chemoembolization, Therapeutic / methods
-
Diagnosis, Differential
-
Echocardiography / methods
-
Humans
-
Intestinal Neoplasms / complications*
-
Intestinal Neoplasms / diagnosis
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary*
-
Magnetic Resonance Imaging / methods*
-
Magnetic Resonance Imaging, Cine / methods
-
Male
-
Myocardium / pathology
-
Octreotide / therapeutic use
-
Tricuspid Valve / surgery
Substances
-
Antineoplastic Agents, Hormonal
-
Octreotide